Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase-Reference-Cited by-同舟云学术

Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase

Published:2020-05-26 Issue:1 Volume:52 Page:196-204
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Lee Han Ah¹^ORCID,Lee Hyun Woong²^ORCID,Kim In Hee³^ORCID,Park Soo Young⁴^ORCID,Sinn Dong Hyun⁵^ORCID,Yu Jung Hwan⁶^ORCID,Seo Yeon Seok¹^ORCID,Um Soon Ho¹^ORCID,Lee Jung Il²^ORCID,Lee Kwan Sik²^ORCID,Lee Chang Hun³^ORCID,Tak Won Young⁴^ORCID,Kweon Young Oh⁴^ORCID,Kang Wonseok⁵^ORCID,Paik Yong-Han⁵^ORCID,Lee Jin-Woo⁶^ORCID,Suh Sang Jun⁷^ORCID,Jung Young Kul⁷^ORCID,Kim Beom Kyung⁸⁹^ORCID,Park Jun Yong⁸⁹^ORCID,Kim Do Young⁸⁹^ORCID,Ahn Sang Hoon⁸⁹^ORCID,Han Kwang-Hyub⁸⁹^ORCID,Yim Hyung Joon⁷^ORCID,Kim Seung Up⁸⁹^ORCID

Affiliation:

1. Korea University College of Medicine; Seoul Korea

2. Gangnam Severance Hospital; Yonsei University College of Medicine; Seoul Korea

3. Chonbuk National University Medical School; Jeonju Korea

4. School of Medicine; Kyungpook National University; Daegu Korea

5. Samsung Medical Center; Sungkyunkwan University School of Medicine; Seoul Korea

6. Inha University Hospital; Inha University School of Medicine; Incheon Korea

7. Korea University Ansan Hospital; Korea University College of Medicine; Ansan Korea

8. Yonsei University College of Medicine; Seoul Korea

9. Yonsei Liver Center; Severance Hospital; Seoul Korea

Funder

National Research Foundation of Korea